ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Specialist

Top Specialist Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ZAHID HAMID M.D.

Specialist

8,733

$458K

342
254 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

24%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $106

C. YEE M. D.

Specialist

6,605

$439K

1393
1317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

1%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

75%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $106

MARIA CORAZON REGALADO MD

Specialist

6,555

$339K

433
285 are 65+

21%
patients receiving schedule two controlled substances

Avg: 10%

21%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $106

BRIAN BERELOWITZ MD

Specialist

6,215

$942K

529
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

2%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

50%
prescriptions for brand name drugs

Avg: 26%

$152
Average prescription price

Avg: $106

GREGORY BRYAN M.D.

Specialist

6,171

$347K

285
202 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

22%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $106

KENNETH WESTFIELD M. D.

Specialist

5,934

$419K

1594
1520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

75%
prescriptions for brand name drugs

Avg: 26%

$71
Average prescription price

Avg: $106

CHRISTOPHER SCULLY M.D.

Specialist

4,491

$732K

386
274 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

19%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$163
Average prescription price

Avg: $106

MORTON HYSON M.D.

Specialist

4,094

$864K

359
182 are 65+

4%
patients receiving schedule two controlled substances

Avg: 10%

23%
patients receiving schedule three controlled substances

Avg: 13%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 26%

$211
Average prescription price

Avg: $106

ALAFURO ORUENE MD

Specialist

3,869

$229K

327
67 are 65+

62%
patients receiving schedule two controlled substances

Avg: 10%

38%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $106

DEVENDRA PATEL M.D., F.A.C.C.

Specialist

3,693

$232K

212
157 are 65+

6%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $106

AREZO FATHIE MD

Specialist

3,480

$242K

106
68 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $106

NAOMI CHANEY M.D..,

Specialist

3,308

$220K

304
243 are 65+

4%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $106

GEORGE KELLY MD

Specialist

3,257

$512K

361
253 are 65+

6%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$157
Average prescription price

Avg: $106

MAHESH KUTHURU MD

Specialist

3,196

$333K

279
55 are 65+

94%
patients receiving schedule two controlled substances

Avg: 10%

30%
patients receiving schedule three controlled substances

Avg: 13%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 26%

$104
Average prescription price

Avg: $106

MICHAEL FINKELSTEIN M.D.

Specialist

3,144

$110K

724
653 are 65+

2%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

7%
prescriptions for brand name drugs

Avg: 26%

$35
Average prescription price

Avg: $106

DONALD HARTLIEB M.D.

Specialist

3,081

$141K

195
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

16%
patients receiving schedule three controlled substances

Avg: 13%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $106

KEITH BOMAN M.D.

Specialist

3,017

$206K

214
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $106

G. BIGLEY M.D.

Specialist

2,766

$1.37M

326
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$496
Average prescription price

Avg: $106

JEFFREY UPTON MD

Specialist

2,745

$215K

492
457 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 26%

$78
Average prescription price

Avg: $106

NAIYERA PARWEEN M.D.

Specialist

2,736

$147K

164
85 are 65+

25%
patients receiving schedule two controlled substances

Avg: 10%

29%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $106

ZEV LAGSTEIN MD

Specialist

2,594

$222K

188
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$86
Average prescription price

Avg: $106

ANTHONY FIELD M.D.

Specialist

2,587

$103K

214
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $106

TERESA BACHMAN M.D.

Specialist

2,559

$579K

238
167 are 65+

5%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 26%

$226
Average prescription price

Avg: $106

LUIS DIAZ M.D.

Specialist

2,529

$1.32M

251
167 are 65+

6%
patients receiving schedule two controlled substances

Avg: 10%

4%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$521
Average prescription price

Avg: $106

MULUGETA KASSAHUN M.D.

Specialist

2,463

$60.8K

711
611 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 13%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

6%
prescriptions for brand name drugs

Avg: 26%

$25
Average prescription price

Avg: $106

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank